Status:
UNKNOWN
Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion
Lead Sponsor:
Beijing Obstetrics and Gynecology Hospital
Conditions:
Intrauterine Adhesion
Eligibility:
FEMALE
20-45 years
Phase:
NA
Brief Summary
Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the trea...
Detailed Description
The diaposable balloon uterine(a special intrauterine balloon) is usually inserted into the uterine after a hysteroscopic adhesiolysis and removed after on the 7th day after surgery. Another group, th...
Eligibility Criteria
Inclusion
- age 20-45 years.
- previously diagnostic hysteroscopy confirmed adhesion score ≧5， according to the American Fertility Society (AFS).
- complains of menstruation disorder and reproductive dysfunction.
- informed consent.
Exclusion
- premature menopause,
- presence of other intrauterine lesions (e.g. polyps, myoma, septa), and
- presence of severe intercurrent illness (e.g. systemic disease, coagulative disorders, severe kidney and liver diseases),
- adhesions limited to the lower uterine cavity or the cervical canal.
Key Trial Info
Start Date :
October 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 25 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03329898
Start Date
October 31 2017
End Date
November 25 2018
Last Update
November 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, China